The effects of cis and trans butenedioic acid on the physicochemical behavior of lumefantrine
- 9 November 2021
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 24 (1) , 156-168
Abstract
A study of the differences in the effects of cis (maleic acid) and trans (fumaric acid) isomers of butenedioic acid on the crystallinity, amorphous nature, and pharmaceutical behaviour of the antimalarial drug lumefantrine is provided.Keywords
Funding Information
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India
- University Grants Commission
This publication has 46 references indexed in Scilit:
- Design and evaluation of Lumefantrine – Oleic acid self nanoemulsifying ionic complex for enhanced dissolutionDARU Journal of Pharmaceutical Sciences, 2013
- Designing Paclitaxel Drug Delivery Systems Aimed at Improved Patient Outcomes: Current Status and ChallengesISRN Pharmacology, 2012
- Neutral and Ionic Supramolecular Complexes of Phenanthridine and Some Common Dicarboxylic Acids: Hydrogen Bond and Melting Point ConsiderationsCrystal Growth & Design, 2011
- Co-Crystals of Sulfamethazine with Some Carboxylic Acids and Amides: Co-Former Assisted Tautomerism in an Active Pharmaceutical Ingredient and Hydrogen Bond Competition StudyCrystal Growth & Design, 2011
- Fluconazole Cocrystals with Dicarboxylic AcidsCrystal Growth & Design, 2010
- DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution ProfilesThe AAPS Journal, 2010
- Synthon Competition and Cooperation in Molecular Salts of Hydroxybenzoic Acids and AminopyridinesCrystal Growth & Design, 2009
- OLEX2: a complete structure solution, refinement and analysis programJournal of Applied Crystallography, 2009
- Poorly Soluble Marketed Drugs Display Solvation Limited SolubilityJournal of Medicinal Chemistry, 2007
- The Salt−Cocrystal Continuum: The Influence of Crystal Structure on Ionization StateMolecular Pharmaceutics, 2007